Apple (NASDAQ: AAPL) has seen significant volatility since the beginning of the year. On December 26, 2024, Apple stock reached an all-time high (ATH) price of $259.02.

DeepSeek's Impact on the Mag 7 Stocks

08:41am, Friday, 31'st Jan 2025
Harvard Business School Professor Mihir Desai breaks down his theory on what this week's Nvidia route can tell us about the future of AI and the danger of placing too much market share in big tech. --
Nasdaq-100 rises as Apple earnings boost tech stocks. Investors await key PCE inflation data for market direction.
AAPL's first-quarter fiscal 2025 results benefit from strong services growth despite a decline in iPhone sales.
Dan Niles, Niles investment Management founder and portfolio manager, joins 'Squawk Box' to discuss Apple's quarterly earnings results, impact of DeepSeek's AI development on Apple, and more.
With new CEO James McDonnell in place and FDA clearance for its Investigational New Drug application, 2025 could be a signpost year for Prescient Therapeutics as it continues to develop PTX-100. It wa
Angelo Zino, Senior Equity Analyst at CFRA Research, raises his price target for Apple to $270, citing the company's resilience despite concerns over China and the lack of an AI offering there. He arg
Apple's China revenues fell 11% YoY. But contrary to what you may think; it does not spell weak demand in that region. In fact, China demand is stronger than expected. Product and iPhone sales have be
Peninsula Energy Ltd expects to begin regulatory inspections and commissioning of the central processing plant (CPP) at the Lance Uranium Project in Wyoming, US, in the June quarter of 2025. The compa
During the last quarter of 2024 Firebird Metals Ltd was busy across its key projects, making progress on its Chinese LMFP battery strategy and forging partnerships to develop the Oakover manganese pro
Race Oncology Ltd made significant progress in the December quarter towards first patient treatment in the Phase 1 trial of RC220 in combination with doxorubicin. The company submitted its ethics and
Race Oncology Ltd made significant progress in the December quarter towards first patient treatment in the Phase 1 trial of RC220 in combination with doxorubicin. The company submitted its ethics and
A look at the day ahead in U.S. and global markets from Mike Dolan
Brookside Energy Ltd sits in a strong cash position for the quarter, achieving A$21.1 million in cash receipts from sales, with net operating cash flow surging 667% quarter-on-quarter to A$12.2 millio
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE